Heterogeneity of viral IL-6 expression in HHV-8-associated diseases. - Wikidata - wikimedia - TriplyDB

Heterogeneity of viral IL-6 expression in HHV-8-associated diseases.

Heterogeneity of viral IL-6 expression in HHV-8-associated diseases.

http://www.wikidata.org/entity/Q30751476

about

Detection of direct binding of human herpesvirus 8-encoded interleukin-6 (vIL-6) to both gp130 and IL-6 receptor (IL-6R) and identification of amino acid residues of vIL-6 important for IL-6R-dependent and -independent signaling Blockade of viral interleukin-6 expression of Kaposi's sarcoma-associated herpesvirus Molecular virology of Kaposi's sarcoma-associated herpesvirus K13 blocks KSHV lytic replication and deregulates vIL6 and hIL6 expression: a model of lytic replication induced clonal selection in viral oncogenesis.Early and sustained expression of latent and host modulating genes in coordinated transcriptional program of KSHV productive primary infection of human primary endothelial cells.High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations Gammaherpesviruses and "Hit-and-Run" oncogenesis.Transcription activation of polyadenylated nuclear rna by rta in human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus.Human herpesvirus 8 (HHV-8)-encoded cytokines induce expression of and autocrine signaling by vascular endothelial growth factor (VEGF) in HHV-8-infected primary-effusion lymphoma cell lines and mediate VEGF-independent antiapoptotic effects How do viruses trick B cells into becoming lymphomas?Evolutionary aspects of oncogenic herpesviruses Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus Characterization of interactions between RTA and the promoter of polyadenylated nuclear RNA in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8.Host pathogen interaction and the development of oral lesions.Immune evasion by Kaposi's sarcoma-associated herpesvirus.Transcriptional regulation of the interleukin-6 gene of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus).Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.The KSHV viral interleukin-6 is not essential for latency or lytic replication in BJAB cells.Kaposi's sarcoma-associated herpesvirus infection of endothelial cells inhibits neutrophil recruitment through an interleukin-6-dependent mechanism: a new paradigm for viral immune evasion The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.HIV-associated multicentric Castleman disease Viral interleukin-6: role in Kaposi's sarcoma-associated herpesvirus: associated malignancies.Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers.The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care.Rhesus macaque rhadinovirus-associated non-Hodgkin lymphoma: animal model for KSHV-associated malignancies.Intracellular signaling mechanisms and activities of human herpesvirus 8 interleukin-6 Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines.Effects of chemotherapy in AIDS-associated non-Hodgkin's lymphoma on Kaposi's sarcoma herpesvirus DNA in blood Targeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignancies.NF-κB as a target for oncogenic viruses.Lytic replication-defective Kaposi's sarcoma-associated herpesvirus: potential role in infection and malignant transformation HHV-8-positive and EBV-positive intravascular lymphoma: an unusual presentation of extracavitary primary effusion lymphoma.Prospects of a novel vaccination strategy for human gamma-herpesviruses.Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV.Inhibition of primary effusion lymphoma engraftment in SCID mice by morpholino oligomers against early lytic genes of Kaposi's sarcoma-associated herpesvirus.A new primary effusion lymphoma-derived cell line yields a highly infectious Kaposi's sarcoma herpesvirus-containing supernatant Kaposi's sarcoma-associated herpesvirus can productively infect primary human keratinocytes and alter their growth properties.Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus

P2860

Q24290902-0BDEDCC8-56DC-4456-93DD-29A9C487B71A Q27486045-D1BB2744-2EB2-402F-BC44-38FEBB06339E Q28363323-F505BF41-B3C0-4D2A-AF8A-F819703A1FAB Q33303677-35BCB96D-1DAE-4FFB-B800-04A23AE5DD60 Q33623056-3EF35416-2537-44B3-83F1-3FCFD40E8185 Q33647633-1E75CD17-9037-4F45-BAAA-9CB0073D68C0 Q33810034-324ADF8C-39A8-4B15-80AC-10CE8E936894 Q33837983-BBC00C9E-CF99-453E-98B1-49F8982F0DF7 Q33849065-306FC028-FE3C-44B5-AD2E-AD9776C8E769 Q34020096-2740E0AF-E1C3-465A-ABAC-503748C83B83 Q34089478-16A99A01-B5D7-45F0-89DE-C83C98A65E79 Q34333321-2BD1BF1A-5467-42A4-8EA6-D3419CD79F33 Q34338900-8139E2B8-BF06-48E4-9CAB-12A575E318FF Q34775211-4C8F86CC-B939-40D2-823F-7098A9743C55 Q34795543-BEC88F8D-C653-44A3-97B5-C4092D384084 Q35000927-854E983D-D803-4931-B857-FCD161025FB7 Q35026060-EB741190-0122-4938-8433-48774A31E8B2 Q35071118-E3D1542B-C6AA-4B16-AB46-A53397CBBAF7 Q35077642-7EF16E40-75F0-4962-BADD-8F690409BB21 Q35104781-B32DDE3D-4AD6-4826-8B90-C72026E22808 Q35127955-8553A55E-91A9-4BA8-BC16-07FD675001A7 Q35226470-00838F58-B514-43FA-A032-1EF723ABC4AC Q35550033-D344E134-B65E-4A8B-B2FF-9234EBABE6AC Q35895560-E4BBC11D-C77B-4443-AA50-804580FC1E9A Q36085023-78B87074-8C41-4185-AFA7-227454929669 Q36969847-3EB8E622-F70A-4B30-8F34-165C8EAA70D3 Q37033410-05C114D9-225D-496E-8A82-EE97DB019431 Q37088015-3967F064-716F-4737-93AB-279665A5029E Q37198986-F821FCA9-186A-4208-93A1-D245D87079C0 Q37235682-A16EF027-0BA2-4B7F-B584-A9107401B9A5 Q37374081-93FB67E2-7376-4F61-9DD9-6B5377E6E377 Q37568044-B3C14802-80E9-4669-8B30-91CEB6D53ADE Q37603069-FE69B550-2200-4810-84DC-EC96711F00E3 Q37780705-9F61E717-0FFA-43E6-AA64-8735EE85E018 Q37865141-E3C87A67-EE15-4811-94AB-33110BE96FE9 Q38073761-5592ABDB-FD09-4CEF-8BA6-25E9B2C42354 Q39494864-303CB6B2-1177-490F-AAF6-7A2963D74FA7 Q39539612-F4C1BCC9-27AC-4FC7-A717-6616053FFB8C Q39605725-C77FE5A9-C88E-4E0E-B380-BDDFD39B1A72 Q39729318-8D64FF65-29BE-449E-B1F3-AFC5478512C7

P2860

Heterogeneity of viral IL-6 expression in HHV-8-associated diseases.

http://www.wikidata.org/entity/Q30751476

description

1999 nî lūn-bûn

@nan

1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Heterogeneity of viral IL-6 expression in HHV-8-associated diseases.

@ast

Heterogeneity of viral IL-6 expression in HHV-8-associated diseases.

@en

type

label

Heterogeneity of viral IL-6 expression in HHV-8-associated diseases.

@ast

Heterogeneity of viral IL-6 expression in HHV-8-associated diseases.

@en

prefLabel

Heterogeneity of viral IL-6 expression in HHV-8-associated diseases.

@ast

Heterogeneity of viral IL-6 expression in HHV-8-associated diseases.

@en

P1433

Q30751476-2857AFF8-3E86-4001-B873-6F456B7B5F1D

P1476

Q30751476-D6B22CA8-410E-405E-B278-48068277F36B

P2093

Q30751476-050744BE-EE51-4C91-B89D-012720E30C20

Q30751476-3CB48AB7-8F67-4AAB-8769-281240A26AAD

Q30751476-3CE3042B-CE25-48EB-9597-9D5D8F87953D

Q30751476-47A6A306-F709-4BEC-8D81-E63E03C52F3D

Q30751476-4EE74EDC-5C32-417F-8FE4-3412B2F42D1B

Q30751476-70643BD3-54E1-4954-9E7D-417C15237900

Q30751476-B801F3DF-A861-4243-A62F-950DE0F984B7

Q30751476-DB0D85A9-5821-47DB-8AFD-23A32524478E

Q30751476-E7CE496A-BA2E-4CB7-BF8D-3FF7355525E8

Q30751476-F9A66F6A-220A-4885-A004-BC96DB981136

P304

Q30751476-AEF3CCBB-8930-4E39-9C40-9B339CCC4A75

P31

Q30751476-916536D8-BB11-437B-92BD-52626B0FE2DF

P356

Q30751476-01FE7A9F-0933-4FBD-B075-65041F7B4C58

P407

Q30751476-BDE8A6A1-401C-4797-B869-044BCF847E3E

P433

Q30751476-A12F32F4-E87C-445C-A83F-8C4D57ABB82D

P478

Q30751476-28251433-AD33-40A8-ABFB-3FA389C83528

P577

Q30751476-61E651E1-0DFB-4343-8195-DF172682B435

P5875

Q30751476-CF70CBDC-72A6-4BC2-9019-73BB3AC2EEFB

P698

Q30751476-0F807DBF-E573-4F2D-9BF0-F3B3D7D6AA6C

P356

P1433

The Journal of Infectious Diseases

P1476

Heterogeneity of viral IL-6 expression in HHV-8-associated diseases.

@en

P2093

Ambinder RF

http://www.w3.org/2001/XMLSchema#string

Browning PJ

http://www.w3.org/2001/XMLSchema#string

Cannon JS

http://www.w3.org/2001/XMLSchema#string

Cesarman E

http://www.w3.org/2001/XMLSchema#string

DiGiuseppe JA

http://www.w3.org/2001/XMLSchema#string

Hayward GS

http://www.w3.org/2001/XMLSchema#string

Mann RB

http://www.w3.org/2001/XMLSchema#string

Murray PG

http://www.w3.org/2001/XMLSchema#string

Nicholas J

http://www.w3.org/2001/XMLSchema#string

Orenstein JM

http://www.w3.org/2001/XMLSchema#string

P304

824-828

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/314956

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

180

http://www.w3.org/2001/XMLSchema#string

P577

1999-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12862155

http://www.w3.org/2001/XMLSchema#string

P698

10438372

http://www.w3.org/2001/XMLSchema#string